aid: immunicon
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immunicon.png
name: Immunicon
description: Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company
  that pioneered immunomagnetic cell-selection technology for isolating and characterizing rare circulating
  tumor cells (CTCs) from blood. It developed the CellSearch and CellTracks diagnostic platforms, licensed to
  Veridex, LLC (a Johnson & Johnson company) for oncology use. Immunicon filed for Chapter 11 bankruptcy in
  2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch platform later passed to Menarini Silicon
  Biosystems. The company was backed by Canaan Partners and publishes no public API or developer surface.
url: https://raw.githubusercontent.com/api-evangelist/immunicon/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Diagnostics
- Oncology
- Medical Devices
- Life Sciences
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence